Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sulzer Intermedics was a leading medical technology company focused on the development and manufacture of cardiac rhythm management devices. The company was a major provider of implantable pacemakers and implantable cardioverter defibrillators (ICDs) used to treat various forms of cardiac arrhythmia. Originally founded as Intermedics, it became a subsidiary of the Swiss industrial group Sulzer AG in the late 1980s. In 1999, the company was acquired by Guidant Corporation for approximately $800 million, which significantly bolstered Guidant's position in the global pacing market. Following subsequent industry consolidations, its technology and product lines became part of Boston Scientific.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sulzer Intermedics.